What is ResBiotic?
ResBiotic is a biotechnology company established in 2020 and headquartered in Birmingham, Alabama. The company is dedicated to developing innovative microbiome-based products specifically for respiratory health. By leveraging the power of the human microbiome, ResBiotic aims to create novel therapeutic solutions for a range of respiratory conditions. The company's focus on this specialized area positions it within the rapidly evolving biotechnology and pharmaceutical sectors, seeking to address unmet medical needs through advanced scientific research and product development.
How much funding has ResBiotic raised?
ResBiotic has raised a total of $3M across 1 funding round:
Angel/Seed
$3M
Angel/Seed (2021): $3M with participation from Timberline Holdings
Key Investors in ResBiotic
Timberline Holdings
Timberline Holdings is a Birmingham-based family investment firm established in 2010, focusing on growth through intelligent and innovative investing across various asset classes including venture, real estate, and private equity. They collaborate with aligned founders to achieve long-term growth and financial stability.
What's next for ResBiotic?
With the recent major strategic investment, ResBiotic is poised for accelerated growth and product development. This capital infusion is expected to fuel advancements in their research pipeline, potentially enabling the company to scale its operations, expand its clinical trials, and bring its microbiome-based respiratory health solutions closer to market. The company's trajectory suggests a move towards later-stage development and commercialization, building upon its foundational research and early-stage backing.
See full ResBiotic company page
